SWITZERLAND — Roche Holding’s much-anticipated Alzheimer’s disease drug failed in two large studies, a new disappointment in a research field riddled with failures. The experimental drug, gantenerumab failed to slow…
Read MoreRoche’s Alzheimer’s drug fails to meet goal in clinical trials
